(Q34395560)

1 August 2017

1 reference

title

Lipid biosynthesis as a target for antibacterial agents (English)

1 reference

1 August 2017

Heath RJ

1

1 reference

1 August 2017

White SW

series ordinal

2

1 reference

1 August 2017

Rock CO

series ordinal

3

1 reference

1 August 2017

publication date

1 November 2001

1 reference

Progress in Lipid Research

1 August 2017

published in

1 reference

1 August 2017

volume

40

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

467-497

1 reference

Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Enzymatic synthesis of a quorum-sensing autoinducer through use of defined substrates.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Generation of cell-to-cell signals in quorum sensing: acyl homoserine lactone synthase activity of a purified Vibrio fischeri LuxI protein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Biosynthesis of pimeloyl-CoA, a biotin precursor in Escherichia coli, follows a modified fatty acid synthesis pathway: 13C-labeling studies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

A new metabolic link. The acyl carrier protein of lipid synthesis donates lipoic acid to the pyruvate dehydrogenase complex in Escherichia coli and mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inhibition of Escherichia coli acetyl coenzyme A carboxylase by acyl-acyl carrier protein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Roles of the FabA and FabZ beta-hydroxyacyl-acyl carrier protein dehydratases in Escherichia coli fatty acid biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inhibition of fatty acid synthesis in Escherichia coli in the absence of phospholipid synthesis and release of inhibition by thioesterase action

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Enoyl-Acyl Carrier Protein Reductase (fabI) Plays a Determinant Role in Completing Cycles of Fatty Acid Elongation in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

On the enzymatic synthesis of unsaturated fatty acids in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Characterization of beta-ketoacyl-acyl carrier protein synthase III from Streptomyces glaucescens and its role in initiation of fatty acid biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

beta-ketoacyl-acyl carrier protein synthase III (FabH) is a determining factor in branched-chain fatty acid biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Purification of NADPH-dependent enoyl-CoA reductase involved in the malonyl-CoA dependent fatty acid elongation system of Mycobacterium smegmatis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Characteristics of short-chain alcohol dehydrogenases and related enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Roles of Tyrosine 158 and Lysine 165 in the Catalytic Mechanism of InhA, the Enoyl-ACP Reductase fromMycobacterium tuberculosis†

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Mechanism of action of diazaborines.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Syntheses and evaluation of benzodiazaborine compounds against M. tuberculosis H37Rv in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Preparation and antibacterial activities of new 1,2,3-diazaborine derivatives and analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Boron-containing antibacterial agents: effects on growth and morphology of bacteria under various culture conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Conditional mutations affecting the cell envelope ofEscherichia coliK-12

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Effect of a diazaborine derivative (Sa 84.474) on the virulence of Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

A diazaborine derivative inhibits lipopolysaccharide biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

envM genes of Salmonella typhimurium and Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

A mechanism of drug action revealed by structural studies of enoyl reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inhibitor binding studies on enoyl reductase reveal conformational changes related to substrate recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

The X-ray structure of Escherichia coli enoyl reductase with bound NAD+ at 2.1 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Molecular genetic analysis of enoyl-acyl carrier protein reductase inhibition by diazaborine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Kinetic mechanism of NADH-enoyl-ACP reductase from Brassica napus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Triclosan: applications and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Antimicrobial spectrum of triclosan, a broad-spectrum antimicrobial agent for topical application. II. Comparison with some other antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Disinfection of the skin with detergent preparations of Irgasan DP 300 and other antiseptics

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Effectiveness of Antibacterial Soaps in a Healthy Population

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Triclosan: a review of effectiveness and safety in health care settings

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Hexachlorophane powder and neonatal staphylococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Behavioral toxicology, risk assessment, and chlorinated hydrocarbons

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

The effectiveness of triclosan-incorporated plastic against bacteria on beef surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Antimicrobial Actions of Hexachlorophene: Lysis and Fixation of Bacterial Protoplasts

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Antimicrobial actions of hexachlorophene: release of cytoplasmic materials.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Do biocides select for antibiotic resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Triclosan targets lipid synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Mechanism of triclosan inhibition of bacterial fatty acid synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Molecular basis of triclosan activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Structural basis and mechanism of enoyl reductase inhibition by triclosan

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Crystallographic analysis of triclosan bound to enoyl reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Molecular basis for triclosan activity involves a flipping loop in the active site

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Antibiotic and biocide resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Triclosan and antibiotic resistance in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

The Internationally Recommended Tuberculosis Control Strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Catalase and peroxidase in mycobacteria. Possible relationship to the mode of action of isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Selective action of isoniazid on the synthesis of cell wall mycolates in mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Synthesis of fatty acids by extracts of mycobacteria and the absence of inhibition by isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Steric course of reaction catalyzed by the enoyl acyl-carrier-protein reductase of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Spontaneous Formation of the Bioactive Form of the Tuberculosis Drug Isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Action mechanism of antitubercular isoniazid. Activation by Mycobacterium tuberculosis KatG, isolation, and characterization of inha inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Isoniazid Inhibition of the Synthesis of Monounsaturated Long-Chain Fatty Acids in Mycobacterium tuberculosis H37Ra

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Ethylenic mycolic acid biosynthesis: extension of the biosynthetic model using cell-free extracts of Mycobacterium aurum and Mycobacterium smegmatis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Global gene expression profiling in Escherichia coli K12. The effects of integration host factor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Susceptibilities of oxyR regulon mutants of Escherichia coli and Salmonella typhimurium to isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Effects of peroxides on susceptibilities of Escherichia coli and Mycobacterium smegmatis to isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

The X-ray crystal structure of beta-ketoacyl [acyl carrier protein] synthase I

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Crystal structure of beta-ketoacyl-acyl carrier protein synthase II from E.coli reveals the molecular architecture of condensing enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Structure of the complex between the antibiotic cerulenin and its target, beta-ketoacyl-acyl carrier protein synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Crystal structure of beta-ketoacyl-acyl carrier protein synthase III. A key condensing enzyme in bacterial fatty acid biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

The 1.8 A crystal structure and active-site architecture of beta-ketoacyl-acyl carrier protein synthase III (FabH) from escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

The action mechanism of cerulenin. I. Effect of cerulenin on sterol and fatty acid biosynthesis in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Substitution of cellular fatty acids in yeast cells by the antibiotic cerulenin and exogenous fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Cerulenin-inhibited cells of Staphylococcus aureus resume growth when supplemented with either a saturated or an unsaturated fatty acid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Cerulenin effect on phospholipid metabolism in Mycobacterium smegmatis ATCC 607

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inhibition of unsaturated fatty acid synthesis in Escherichia coli by the antibiotic cerulenin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inhibition of fatty acid synthesis by the antibiotic cerulenin. Specific inactivation of beta-ketoacyl-acyl carrier protein synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inhibition of fatty acid synthetases by the antibiotic cerulenin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

beta-Ketoacyl-ACP synthase I of Escherichia coli: nucleotide sequence of the fabB gene and identification of the cerulenin binding residue.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Mechanism of action of cerulenin on fatty acid synthetase. Effect of cerulenin on iodoacetamide-induced malonyl-CoA decarboxylase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Reaction of Yeast Fatty Acid Synthetase with Iodoacetamide. 3. Malonyl-Coenzyme A Decarboxylase as Product of the Reaction of Fatty Acid Synthetase with Iodoacetamide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Thiolactomycin, a new antibiotic. II. Structure elucidation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Structure of thiolactomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Thiolactomycin, a new antibiotic. I. Taxonomy of the producing organism, fermentation and biological properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Thiolactomycin, a new antibiotic. III. In vitro antibacterial activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Antimicrobial activities of thiolactomycin against gram-negative anaerobes associated with periodontal disease. f1

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Mechanism of action of the antibiotic thiolactomycin inhibition of fatty acid synthesis of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inhibition of fatty acid synthesis by the antibiotic thiolactomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Specialized fatty acid synthesis in African trypanosomes: myristate for GPI anchors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Thiolactomycin, a new antibiotic. IV. Biological properties and chemotherapeutic activity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Thiolactomycin resistance in Escherichia coli is associated with the multidrug resistance efflux pump encoded by emrAB

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Overproduction of beta-ketoacyl-acyl carrier protein synthase I imparts thiolactomycin resistance to Escherichia coli K-12

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Effect of thiolactomycin on the individual enzymes of the fatty acid synthase system in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Novel inhibitors of the condensing enzymes of the type II fatty acid synthase of pea (Pisum sativum).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

On the mode of interaction of -hydroxydecanoyl thioester dehydrase with allenic acid derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Structure of a dehydratase-isomerase from the bacterial pathway for biosynthesis of unsaturated fatty acids: two catalytic activities in one active site

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Suicide substrates, mechanism-based enzyme inactivators: recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Overproduction of acetyl-CoA carboxylase activity increases the rate of fatty acid biosynthesis in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Synthesis of a reaction intermediate analogue of biotin-dependent carboxylases via a selective derivatization of biotin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Inhibition of biotin carboxylase by a reaction intermediate analog: implications for the kinetic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Three-dimensional structure of the biotin carboxylase subunit of acetyl-CoA carboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Movement of the biotin carboxylase B-domain as a result of ATP binding

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Antibacterial activity of phenolic compounds and aromatic alcohols

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Antibacterial activity of phenethyl alcohol and resulting membrane alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Effects of temperature variation and phenethyl alcohol addition on acyl chain order and lipid organization in Escherichia coli derived membrane systems. A 2H- and 31P-NMR study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Effects of Phenethyl Alcohol on Phospholipid Metabolism in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Fatty acid synthesis in Escherichia coli is indirectly inhibited by phenethyl alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Purification and reconstitution of murine mitochondrial glycerol-3-phosphate acyltransferase. Functional expression in baculovirus-infected insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

A gene (plsD) from Clostridium butyricum that functionally substitutes for the sn-glycerol-3-phosphate acyltransferase gene (plsB) of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Analysis of amino acid motifs diagnostic for the sn-glycerol-3-phosphate acyltransferase reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

sn-Glycerol-3-phosphate auxotrophy of plsB strains of Escherichia coli: evidence that a second mutation, plsX, is required

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Antibacterial agents that inhibit lipid A biosynthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Antibacterial agents that target lipid A biosynthesis in gram-negative bacteria. Inhibition of diverse UDP-3-O-(r-3-hydroxymyristoyl)-n-acetylglucosamine deacetylases by substrate analogs containing zinc binding motifs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

A left-handed parallel beta helix in the structure of UDP-N-acetylglucosamine acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

The effect of diflufenican on lipid metabolism in plants

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Clinical Experiences in Cases of Primary Tuberculosis with Tuberculostaticum Isoxyl

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Isoxyl: A Review of the Results of its Use Over a Five-Year Period in the Tuberculosis Field Service of a Large Urban Area

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Effects of Ethionamide and Isoxyl on Mycolic Acid Synthesis in Mycobacterium tuberculosis bcg

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Cloning, sequencing, and expression of the pantothenate kinase (coaA) gene of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Cloning and characterization of a eukaryotic pantothenate kinase gene (panK) from Aspergillus nidulans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Pantothenate kinase regulation of the intracellular concentration of coenzyme A.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Cloning, overproduction, and characterization of the Escherichia coli holo-acyl carrier protein synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Biochemical and molecular analyses of the Streptococcus pneumoniae acyl carrier protein synthase, an enzyme essential for fatty acid biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Crystal structure of Streptococcus pneumoniae acyl carrier protein synthase: an essential enzyme in bacterial fatty acid biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Crystal structures of substrate binding to Bacillus subtilis holo-(acyl carrier protein) synthase reveal a novel trimeric arrangement of molecules resulting in three active sites

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

Identification and analysis of the acyl carrier protein (ACP) docking site on beta-ketoacyl-ACP synthase III

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

The X-ray structure of Brassica napus beta-keto acyl carrier protein reductase and its implications for substrate binding and catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2801%2900012-1

7 January 2021

10.1016/S0163-7827(01)00012-1

Identifiers

DOI

1 reference

1 August 2017

1 reference